Article
Atypical antipsychotic (AAP)-induced metabolic toxicity : study of mechanisms, biomarkers and reversal strategies
2018-01-01
Abstract excerpt
Atypical antipsychotics are commonly prescribed for the treatment of psychiatric disorders such as schizophrenia. However, long term use of atypical antipsychotics lead to metabolic adverse effects such as weight gain, insulin resistance, and dyslipidemia, all of which are independent risk factors for cardiometabolic disease. Adipose tissue plays an important role in glucose and lipid homeostasis and has been link...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5ab3402a-6e86-5f15-973d-c3700c94119c
- DOI
- 10.17638/03020043
